4:31 PM
 | 
Nov 13, 2017
 |  BC Extra  |  Company News

Pfizer ends JV with Hisun, names COO

Pfizer Inc. (NYSE:PFE) sold its 49% stake in Chinese JV Hisun-Pfizer Pharmaceuticals Co. Ltd. to Sapphire I (HK) Holdings Ltd. Hisun-Pfizer was formed in 2012 with Zhejiang Hisun Pharmaceutical Co. Ltd. (Shanghai:600267), which owns 51% of the JV, to develop and commercialize generics in China and worldwide (see BioCentury Extra, Feb. 17, 2012).

In its 3Q17 earnings report filed last Thursday, Pfizer said that last year the JV had...

Read the full 327 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >